Product Theater and Lunch Delaying Time to Relapse in Adult Patients With Schizophrenia Supported by Janssen Pharmaceuticals, Inc.
Registration Options
Activity Date: 04/24/2022
AAPP 2022 registration is closed.
Session Time and Location
The live session is complete.
Session Summary
The presentation will begin after in-person meals are served (an estimated 15-30 minute delay). Thank you for your patience.
During this presentation, Kristin Waters, PharmD will discuss how Janssen’s long-acting Injectable (LAI) can delay time to relapse for adult patients with schizophrenia.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
AAPP websites use cookies to personalize and enhance your experience.
By continuing to use the site, you agree to this collection.
Learn more.
System Update:
We are undergoing major upgrades right now, and we appreciate your patience.
If you need help, please use the support chat or email info@aapp.org.
Learn more.
